Paydirt
JC
Insider

Jeffrey Del Carmen

Chief Commercial Officer

Jeffrey Del Carmen (Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in CPRX. The largest single filing was $256K of CPRX (10,983 sh × $23.33, as filed), executed Nov 26 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$256K
shares × price, as filed
Last traded
Nov 26 2025
Filed Nov 28 2025
Open performance→
Volume by month
$696K$348K$0Oct 2024Apr 2025Oct 2025Apr 2026Mar 2025 · sells $696KNov 2025 · sells $256K
Buys $0 Sells $953K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names
CPRX CPRX CPRX · 0 buys · 2 sells 2 filings
Recent filings
CPRXSALE CATALYST PHARMACEUTICALS, INC. View filing → $256K
10,983 sh × $23.33
Exec Nov 26 2025
Filed Nov 28 2025 · 5:30 PM ET CPRXSALE CATALYST PHARMACEUTICALS, INC. View filing → $696K
30,423 sh × $22.89
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET